|
|
Article: GlaxoSmithKline Renews BioExpress Subscription with Gene Logic; Continues Use of Comprehensive Gene Expression Tool Begun in Late 2001.
- Article from:
- Business Wire
- Article date:
- December 22, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
BIOWIRE2K
GAITHERSBURG, Md.--(BUSINESS WIRE)--Dec. 22, 2003
Gene Logic Inc. (Nasdaq:GLGC) today announced that GlaxoSmithKline (NYSE:GSK) (GSK), a leading global pharmaceutical company, has renewed its subscription to Gene Logic's BioExpress(TM) System for use in GSK's primary discovery initiatives. Financial details of the two-year renewal agreement were not disclosed.
Gene Logic Overview
Gene Logic is a contract ...